Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use.
Akura Medical has raised $53.0M in total funding. The most recent round was Series C. The last funding was announced in December 2025.
Akura Medical's investors include Cormorant Asset Management, Qatar Investment Authority, Lilly Asia Ventures, MedTech Venture Partners, Unorthodox Ventures.
Akura Medical is headquartered in Los Gatos, United States.
Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use.
Akura Medical is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akura Medical — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/akura-medical. Accessed October 29, 2026.
VCBacked. (2025). Akura Medical — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/akura-medical
{{cite web |title=Akura Medical — Funding & Investors |url=https://www.vcbacked.co/company/akura-medical |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated